ArticleFrontiers in medicine2026
Pathologic myopia as a concurrent condition in Pierre Robin sequence: a case report and literature review.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Pierre Robin sequence (PRS) is a rare congenital disorder often associated with multisystem abnormalities, yet cases combined with pathologic myopia and medial upper eyelid entropion with trichiasis in whom no pathogenic genetic variants are detectable are rare. Case presentation: This article reports on a 4-year-old male child with syndromic PRS, whose parents verbally stated that no pathogenic variants were identified in previous genetic testing. Since birth, he has undergone multiple surgeries for micrognathia, cleft palate, and secretory otitis media. He presented for ophthalmic evaluation due to high myopia in both eyes. Ocular examinations revealed the following: best-corrected visual acuity (BCVA) was 0.12 in the right eye and 0.1 in the left eye; bilateral medial upper eyelid entropion with trichiasis was observed, accompanied by rough nasal corneal epithelium; the fundus showed tessellated appearance with Grade A2 macular atrophy. The axial length was 31.38 mm in the right eye and 32.13 mm in the left eye, and optical coherence tomography indicated choroidal thinning. The child underwent bilateral posterior scleral reinforcement (PSR). During the 35-month postoperative follow-up, the child underwent second-stage bilateral upper eyelid entropion correction and trialed low-vision aids and acupuncture. Currently, the child's BCVA is 0.3 in the right eye and 0.12 in the left eye while near vision reaches 0.8 at 10 cm with the use of spectacle- mounted near low-vision aids. Axial length growth has slowed compared to pre-operative rates, The rate of axial length growth has slowed compared to the pre-operative period, and the fundus condition remains stable. Conclusion: Syndromic PRS can be associated with complex ocular abnormalities. Even in cases where no pathogenic genetic variants are identified, multidisciplinary management is crucial. PSR, entropion correction, and early low vision rehabilitation interventions can effectively improve prognosis. Multidisciplinary collaboration and long-term follow-up are essential components of care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.